Trials / Completed
CompletedNCT05865431
Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light
Detailed description
Ultraviolet (UV) radiation can lead to skin damage and cancer. Ultraviolet A (UVA) irradiation is 10 to 100 times more abundant in natural sunlight than ultraviolet B (UVB), thus human skin is exposed to more UVA irradiation daily.UVA irradiation is not completely filtered by clothing and it penetrates deeper into the dermis than UVB, potentially causing more damage. It is believed that skin cancer, photo aging, and skin immunomodulation are mediated by the reactive oxygen species (ROS) that are generated in response to UV radiation. Singlet oxygen (1O2) is one type of ROS. The aim of this study is to quantify the level of singlet oxygen generated in the skin after exposure to UVA radiation. Previous studies have used low dose ultraviolet A1(UVA1) irradiation of 20 J/cm2, which mimics exposure to strong sunlight of approximately two hours. This study will use UVA doses equivalent to or less than what humans are exposed to in daily life. Additionally, the aim is to quantify singlet oxygen produced in individuals of various skin types before and after application of sunscreens containing zinc oxide and avobenzone (sun protection factor 30). To our knowledge, there is no method for quantifying singlet oxygen in human skin after exposure to UVA light. This is a novel method that may help the investigators understand further the protective effects of various skin types, as well as sunscreens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zinc Oxide and Avobenzone | Zinc Oxide is applied to one area of the forearm, Avobenzone is applied to another area of the forearm. |
Timeline
- Start date
- 2017-03-17
- Primary completion
- 2018-02-02
- Completion
- 2018-02-02
- First posted
- 2023-05-18
- Last updated
- 2025-04-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05865431. Inclusion in this directory is not an endorsement.